These findings could inform cancer immunotherapeutic strategies for targeting MAGEA antigens and provide mechanistic insight into the divergent roles of MAGEA6 during pancreatic cancer initiation and progression. This evidence concerns the gene MAGEA6 and pancreatic neoplasm.